Streetbeat News

Stock Prices

ADBE

A significant bearish stance has been taken on Adobe (NASDAQ:ADBE) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split, with 42% bullish and 57% bearish. The whales have been targeting a price range from $480.0 to $550.0 for Adobe over the last 3 months. Morgan Stanley has upgraded Adobe to Overweight with a price target of $660.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 1:47 pm

AMC

AMC Entertainment Holdings Inc. reported record admissions revenue for the week of July 21-27, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 1:46 pm

NVO

Novo Nordisk's weight-loss drug, Wegovy, has launched in Germany, marking its first significant European market entry. The drug is already available in the U.S., Norway, and Denmark. Despite concerns about supply constraints, the company expects German consumers to cover the drug's expenses as public health insurance cannot cover it. The launch is seen as a positive development given Germany's adult obesity rate of 18.5%, higher than the EU average.

Portfolio Pulse from Vandana Singh

July 31, 2023 | 1:45 pm

ACHR

Archer Aviation Inc has entered into contracts with the US Air Force, with a total value of up to $142 million. This has led to a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 1:45 pm

SPY

The Chicago Purchasing Managers' Index (PMI) for July came in at 42.8, slightly below the estimated 43 but higher than the prior month's 41.5.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 1:45 pm

APLS

Apellis Pharmaceuticals Inc reported Q2 EPS loss of $1.02, beating the consensus of -$1.35. Sales were $95 million, up from $16.3 million a year ago, beating the consensus of $71.72 million. The sales included $22.3 million of the U.S. net product revenue of Empaveli and $67.3 million of the U.S. net product revenue of Syfovre. Despite the positive financial results, the company's stock price fell by more than 10.2%.

Portfolio Pulse from Vandana Singh

July 31, 2023 | 1:45 pm

NAVB

Navidea Biopharmaceuticals Inc (NASDAQ:NAVB) shares have dropped by 18.5% to $0.08 after the company announced that NYSE American has started delisting proceedings. The company plans to appeal the decision and if delisted, Navidea intends to quote its common stock in the over-the-counter market.

Portfolio Pulse from Henry Khederian

July 31, 2023 | 1:39 pm

YELL

Trading of Yellow Corporation's shares has resumed.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 1:38 pm

YELL

MFN Partners LP has reported a 24.6% stake in Yellow Corporation as of July 20, according to a 13D filing with the SEC.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 1:37 pm

IONQ

IonQ Inc's shares are trading higher due to rumors of a potential buyout and a bullish mention in a newsletter. The company, known for its quantum computing technology, is expected to report its Q2 financial results on Aug. 10, with an estimated loss of 13 cents per share on quarterly revenue of $4.35 million.

Portfolio Pulse from Adam Eckert

July 31, 2023 | 1:37 pm